Back to All Collaborations

mVacciNation Partnership

Active Since: 2014

Contributing to SDGs…

Improving immunisation coverage through reducing drop-out rates in under 5s, through an interoperable mobile phone technology solution that complements the Ministry of Health’s technology solutions to address vaccine supply and cold chain bottlenecks.

PARTNER ORGANISATIONS

  • Bilateral Organisations

    US Agency for International Development (USAID)

  • Global NGOs

    African Medical and Research Foundation (AMREF)

    Contribution

    Implementing partners: AMREF in Tanzania; Adam Smith International in Nigeria

    Adam Smith International

    Contribution

    Implementing partners: AMREF in Tanzania; Adam Smith International in Nigeria.

  • Government

    Mozambique Ministry of Health

  • Intergovernmental Organizations and Multilaterals

    GAVI Alliance

  • Telecoms

    Vodafone

Objectives

  • Increase demand for immunisation services and reduce non-compliance.
  • Optimise the supply chain.
  • Replace paper-based systems at point of service delivery.

What are the health needs and challenges?

Despite major advances in the funding and availability of vaccines worldwide, it is estimated that up to a fifth of children worldwide still do not receive basic vaccines. The proliferation of mobile phones in Africa offers an opportunity to create innovative and cost-effective ways to address barriers to universal vaccination.

Partnership activities and how they address needs and challenges

mVacciNation is an interoperable mobile phone technology solution that complements the Ministry of Health’s technology solutions to address vaccine supply and cold chain bottlenecks, and ultimately improve immunisation coverage through reducing drop-out rates in under 5s.

GSK, Vodafone, Gavi and USAID have been working together with local Ministries of Health and in-country implementation partners to improve immunisation coverage since 2012. The partnership combines GSK’s healthcare and vaccine expertise with Vodafone’s expertise, enabling mobile technology to help vaccinate children against common infectious diseases in Africa.
The initial focus of the partnership was a one-year pilot vaccination project in Mozambique, in collaboration with the Mozambique Ministry of Health. This project aimed to establish if mobile technology solutions could increase the proportion of children covered by vaccination in Mozambique by an additional 5-10% through helping to encourage mothers to take up vaccination services, support health workers, improve record keeping, and enable better management of vaccine stock.

Following direct requests from local Ministries of Health, in 2016 we launched further pilot programmes in 50 facilities in both Tanzania and Nigeria, partnering with Amref Africa and Adam Smith International respectively. As of January 2019, across the three countries 183,977 children have been registered into the system, successfully recording 955,558 antigen/vaccine administrations.

The project uses mobile technology to address barriers to increased take-up of vaccines in three key ways:

Mothers and caregivers are registered on the mVacciNation database and alerted by SMS to the availability and importance of lifesaving vaccinations against common childhood diseases. Mothers are able to schedule vaccination appointments by SMS and receive notifications of past and future vaccinations to ensure children complete the full schedule and become fully immunised.

Health workers are provided with smartphones with software allowing them to contact mothers, view and record vaccination histories, schedule vaccinations and report on follow-up visits.

Healthcare facilities are prompted to regularly report on crucial vaccination stock levels by SMS. This enables critical supply chain management and the availability of vaccines when and where they are needed, particularly in rural areas.

With funding from USAID and GAVI, the pilot in Mozambique is being independently evaluated by the J-PAL Africa research unit, based at the University of Cape Town (UCT), and the National Institute of Health of Mozambique. The UCT team includes researchers from Yale University and Harvard School of Public Health. The evaluation will rigorously measure the impact of the program as well as assess its cost effectiveness, helping to inform scale-up decisions both across Mozambique and in other African countries.

SDGs THE PARTNERSHIP CONTRIBUTES TO

SDG 3: Good Health and Wellbeing

  1. 3.1: Reduce Maternal Mortality
  2. 3.2: Reduce Under-5 Mortality 
  3. 3.3: Communicable Diseases & NTDs
  4. 3.7: Access to sexual and reproductive health-care services 

SDG 5: Gender Equality

SDG 10: Reduced Inequalities

SDG 17: Partnerships for the Goals 

RESULTS & MILESTONES

As of January 2019, across the three countries (Mozambique, Tanzania, Nigeria) 183,977 children have been registered into the system, successfully recording 955,558 antigen/vaccine administrations.